v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net cash used in operating activities $ (12,630) $ (15,944)
Cash flows from investing activities:    
Purchases of property and equipment (116) (661)
Net cash used in investing activities (116) (661)
Cash flows from financing activities:    
Merger and PIPE financing, net of transaction costs 0 15,874
Payment of deferred offering costs 0 (4,531)
Proceeds from exercise of stock options 58 0
Cash provided by (used in) financing activities 58 11,343
Effect of exchange rate changes on cash, cash equivalents and restricted cash 121 0
Net change in cash, cash equivalents and restricted cash (12,567) (5,262)
Cash, cash equivalents and restricted cash at beginning of period 46,050 50,488
Cash, cash equivalents and restricted cash at end of period 33,483 45,226
Components of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 33,219 44,967
Restricted cash (included within other assets) 264 259
Total cash, cash equivalents and restricted cash 33,483 45,226
Supplemental non-cash disclosures:    
Property and equipment acquired in accounts payable and accrued expenses 222 497
Conversion of Legacy Blaize convertible notes to common stock 0 314,334
Net exercise of Legacy Blaize warrants for common stock 0 75,056
Issuance of warrants for professional services 0 167
Issuance of common stock for shareholder note receivable $ 0 $ 8,754